Atezolizumab (atezo) plus platinum/gemcitabine (plt/gem) vs placebo plus plt/gem in patients (pts) with previously untreated locally advanced or metastatic urothelial carcinoma (mUC): Updated overall survival (OS) from the randomized phase III study IMvigor130.

 
This item is provided by the institution :

Repository :
Pergamos Digital Library
see the original item page
in the repository's web site and access all digital files if the item*
share



Semantic enrichment by EKT
Journal part (EN)
Scientific article (EN)
2021 (EN)
Atezolizumab (atezo) plus platinum/gemcitabine (plt/gem) vs placebo plus plt/gem in patients (pts) with previously untreated locally advanced or metastatic urothelial carcinoma (mUC): Updated overall survival (OS) from the randomized phase III study IMvigor130.
Galsky, Matthew D. Arranz, Jose Angel Grande, Enrique De Santis, Maria Davis, Ian D. Kikuchi, Eiji Garcia del Muro, Xavier Park, Se Hoon De Giorgi, Ugo Alekseev, Boris and Mencinger, Marina Izumi, Kouji Puente, Javier Li, Jian-Ri and O'Donnell, Peter H. Shen, Xiaodong Lee, Chooi Mecke, Almut Mariathasan, Sanjeev Bamias, Aristotelis
scientific_publication_article
Επιστημονική δημοσίευση - Άρθρο Περιοδικού (EL)
Scientific publication - Journal Article (EN)
University of Athens
Pergamos Digital Library
Journal Article
English
2021-01-01
uoadl:3029633
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3029633



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)